Back to top
more

Global Medical REIT (GMRE)

(Delayed Data from NYSE)

$8.11 USD

8.11
326,587

+0.02 (0.25%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $8.11 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (156 out of 252)

Industry: REIT and Equity Trust - Other

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for GMRE

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Global Medical REIT Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 7 14 13 11 7
Receivables 0 0 0 0 0
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 0 0 0 0 0
Total Current Assets 7 14 13 11 7
Net Property & Equipment 0 0 0 0 0
Investments & Advances 1,180 1,294 1,206 1,053 852
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 27 30 25 20 15
Intangibles 6 6 6 6 0
Deposits & Other Assets 48 50 14 11 11
Total Assets 1,268 1,393 1,263 1,101 885
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 26 58 57 65 39
Accounts Payable 13 14 10 7 5
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 39 71 68 72 44
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 589 642 519 526 356
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 34 31 39 45 25
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 662 744 626 643 425
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 75 75 75 75 75
Common Stock (Par) 0 0 0 0 0
Capital Surplus 722 722 711 505 433
Retained Earnings -239 -199 -157 -117 -71
Other Equity 47 51 8 -5 23
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 606 649 638 458 460
Total Liabilities & Shareholder's Equity 1,268 1,393 1,263 1,101 885
Total Common Equity 531 574 563 383 385
Shares Outstanding 65.50 65.50 64.20 48.10 36.80
Book Value Per Share 8.10 8.77 8.76 7.96 10.47

Fiscal Year End for Global Medical REIT Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 7 8 10 14
Receivables NA 0 0 0 0
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 0 0 0 0
Total Current Assets NA 7 8 10 14
Net Property & Equipment NA 0 0 0 0
Investments & Advances NA 1,180 1,202 1,223 1,276
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 27 27 26 30
Intangibles NA 6 6 6 6
Deposits & Other Assets NA 48 60 56 43
Total Assets NA 1,268 1,303 1,321 1,369
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 26 57 57 57
Accounts Payable NA 13 13 15 13
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 39 70 73 70
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 589 565 572 639
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 34 35 31
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 662 669 679 741
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 75 75 75 75
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 722 722 722 722
Retained Earnings NA -239 -224 -214 -212
Other Equity NA 47 61 58 43
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 606 634 641 628
Total Liabilities & Shareholder's Equity NA 1,268 1,303 1,321 1,369
Total Common Equity 0 531 559 566 554
Shares Outstanding 65.50 65.50 65.50 65.50 65.50
Book Value Per Share 0.00 8.10 8.53 8.65 8.45